Skip to main content
[Preprint]. 2021 Oct 15:2021.10.03.21264320. [Version 2] doi: 10.1101/2021.10.03.21264320

Figure 1: Binding antibody responses to spike RBD following one and two COVID-19 vaccine doses.

Figure 1:

Panel A: Binding antibody responses to the SARS-CoV-2 spike RBD in serum following one dose of a COVID-19 vaccine in PLWH (black circles) and controls (grey circles) who were COVID-19 naive at study entry. Convalescent participants, denoting those with anti-N antibodies at study entry, are colored as above. Red bars and whiskers represent the median and IQR. P-values were computed using the Mann-Whitney U-test and are uncorrected for multiple comparisons. LLOD: lower limit of detection. ULOQ: upper limit of quantification. Panel B: Binding antibody responses after two vaccine doses, colored as in A. Panel C: Correlation between most recent CD4+ T-cell count and binding antibody responses after one dose (red circles) and two doses (blue circles). Dotted lines are to help visualize the trend.